Short Interest in Click Holdings Limited (NASDAQ:CLIK) Decreases By 29.1%

Click Holdings Limited (NASDAQ:CLIK) saw a significant decline in short interest in December. As of December 15th, there was short interest totaling 9,893 shares, a decline of 29.1% from the November 30th total of 13,952 shares. Approximately 0.9% of the shares of the stock are short sold. Based on an average daily volume of 89,670 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily volume of 89,670 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.9% of the shares of the stock are short sold.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Click in a research note on Monday, December 22nd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Click Price Performance

Click stock opened at $5.42 on Tuesday. Click has a fifty-two week low of $4.80 and a fifty-two week high of $102.90. The stock has a fifty day moving average of $6.44 and a two-hundred day moving average of $9.04.

About Click

Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.